Scholarlink

<p>The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) is an organization of healthcare providers, researchers, and advocates whose mission is to be a leading global authority in advancing the science and clinical management of hereditary gastrointestinal cancer syndromes. In 2024, the Executive Council developed a Strategic Plan, outlined here, to guide the organization’s work over the next 3&#xa0;years. The Strategic Plan is based on the four pillars of Education, Discovery &amp; Innovation, Community &amp; Collaboration, and Organizational Vitality, with associated goals, action plans, and metrics for each pillar. Ultimately, the Strategic Plan will help CGA-IGC fulfill its vision and mission to advance the science and clinical management of hereditary gastrointestinal cancers.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Strategic Plan of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC): A practical roadmap to move the hereditary gastrointestinal cancer field forward

  • 期刊论文

  • 发表日期：

    2025年6月1日

查看全文
  • Bryson W. Katona,
  • Peter P. Stanich,
  • Anu Chittenden,
  • Michael J. Hall,
  • Gregory E. Idos,
  • Cathryn Koptiuch,
  • Alicia Latham,
  • Rachel Pearlman,
  • Aparajita Singh,
  • Elana Levinson,
  • Beth Dudley

摘要

The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) is an organization of healthcare providers, researchers, and advocates whose mission is to be a leading global authority in advancing the science and clinical management of hereditary gastrointestinal cancer syndromes. In 2024, the Executive Council developed a Strategic Plan, outlined here, to guide the organization’s work over the next 3 years. The Strategic Plan is based on the four pillars of Education, Discovery & Innovation, Community & Collaboration, and Organizational Vitality, with associated goals, action plans, and metrics for each pillar. Ultimately, the Strategic Plan will help CGA-IGC fulfill its vision and mission to advance the science and clinical management of hereditary gastrointestinal cancers.